Breakthrough in Infant Nutrition: Human Milk Fortifier Approved
FDA Approves Innovative Human Milk Fortifier for Infants
Prolacta Bioscience is making strides in neonatal care with its new product, Surgifort® Human Milk Fortifier. This revolutionary nutritional fortifier, designed for term infants, has recently received approval from the U.S. Food and Drug Administration (FDA). It marks a significant advancement in specialized nutrition for babies who have undergone corrective surgery for gastroschisis.
Understanding Surgifort and Its Importance
Surgifort is the first human milk-based nutritional fortifier indicated specifically for term infants who are recovering from gastrointestinal anomalies. Developed in response to the nutritional needs of these fragile infants, this product is a game changer. It contains a carefully balanced mix of protein, calories, and essential nutrients derived from 100% human milk, aimed at enhancing growth and recovery.
What is Gastroschisis?
Gastroschisis is a complex birth defect where a newborn's intestines are found outside of the body due to an opening in the abdominal wall. This condition requires immediate medical intervention, often involving surgery to reposition the organs. Babies born with this condition, like premature infants, face nutritional challenges that require high macronutrient intake for recovery and healthy growth.
The Role of Human Milk Nutrition
Human milk nutrition has long been recognized for its superior benefits, particularly for vulnerable infants. With the introduction of Surgifort, Prolacta aims to expand its benefits beyond preterm infants to those like term infants recovering from gastroschisis surgery. Mixing Surgifort with human milk offers clinicians a tailored solution to meet the unique nutritional needs of these babies, ensuring they receive optimal support during a critical recovery period.
Clinical Benefits and Research
Research has shown that Surgifort can significantly improve growth rates and reduce the time required to establish full feeds in surgical infants. During clinical evaluations, infants who received this fortifier exhibited improved weight gain, averaging 33.3 grams per day from the start of treatment. This evidence underscores the fortifier's role in supporting healthy development during a challenging phase of recovery.
Commitment to Quality and Safety
Prolacta Bioscience operates with a steadfast commitment to safety and quality in its production processes. The company employs rigorous testing protocols to ensure its products meet the highest standards. With over 100,000 infants benefiting from their human milk-based products, they continue to lead the way in ensuring that fragile babies receive the best possible care.
About Prolacta Bioscience
Prolacta Bioscience is a global leader in human milk-based nutrition, dedicated to improving health outcomes for critically ill and premature infants. They have pioneered the science of human milk and own the world's first pharmaceutical-grade human milk processing facilities. Through a commitment to advancing quality care, Prolacta is changing lives every day.
For further information regarding Surgifort and its applications, you can reach Prolacta directly, where their team is eager to support healthcare providers in delivering enhanced nutrition options for infants.
Frequently Asked Questions
What is Surgifort used for?
Surgifort is a human milk-based fortifier designed for term infants recovering from surgery for gastroschisis.
How does Surgifort benefit term infants?
This product delivers essential nutrients, helping to promote optimal growth and recovery during a critical time for these infants.
Why is human milk important for surgical infants?
Human milk contains vital nutrients that support growth, improve digestive health, and enhance overall recovery for infants recovering from surgeries.
How has Prolacta ensured the safety of this product?
Prolacta follows strict quality and safety standards, employing thorough testing at their pharmaceutical-grade facilities.
Where can healthcare professionals learn more about Surgifort?
Healthcare providers can visit Prolacta's website for detailed information and resources on Surgifort and other nutritional solutions.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.